Panacea Biotec Limited has informed the Exchange that the Board of directors in its meeting held on 15.12.2025, considered and adopted the revised Policy for determining Materiality of Events / Information and also authorised few persons as KMP for the purpose of determining materiality of an event or information & making disclosures to the stock exchange(s)'.'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On December 15, 2025, the Board of Directors of Panacea Biotec reviewed and adopted a revised Policy for determining the Materiality of Events or Information, in line with regulatory disclosure norms. The Board also authorised certain persons as Key Managerial Personnel (KMP) responsible for assessing whether an event qualifies as material and for making timely disclosures to the stock exchanges. This is a routine corporate governance update required under SEBI's Listing Regulations. There are no financial, operational, or strategic details revealed in this filing.
This is a procedural governance update with no direct impact on the company's financials, business, or shareholder value. Investors should view it as routine compliance housekeeping rather than a price-moving announcement.